Seeking capital.
We have developed a pipeline of acquisition targets totaling over $200M in enterprise value, have significant resources to get deals to the finish line, and have world-class advisors and operators to execute post-close growth mandates. We are seeking an equity partner to join us as we seek to create the healthcare system of the future by consolidating healthcare services and technology that improves health outcomes and healthcare system efficiencies.
About us:
As a North American lower middle market healthcare consolidation and innovation platform serving aging and chronically ill populations, New Health Investment Group (“New Health” or “NHIG”) is creating the healthcare system of the future by consolidating healthcare services and technology that improve health outcomes and healthcare system efficiencies. With initial investments in the U.S., New Health is seeking to build a valuable corporate platform up to $500 million in sales as a respected high-growth and profitable leader in the industry for the long-term.
The New Health team holds over 200 years of experience, and combined, has closed hundreds of deals totaling tens of billions in enterprise value. New Health brings together extensive experience in private equity, venture capital, due diligence, finance, law, strategy, science, data, technology, digital transformation, and operations across the healthcare continuum.
We intend to acquire companies at purchase prices between 3-10x EBITDA at an average of 6x. We expect to achieve an exit multiple of 10x within the following 5 years via strategic sale or IPO, which we believe is conservative given that the industry average exit multiple is above 12x.
Please contact Kirk Johnson:
--@----.com
+###-###-####
industry
Healthcare
Healthcare
location
New York, NY, USA
New York, NY, USA
revenue
$200,000,000
$200,000,000
ebitda
$30,000,000
$30,000,000
To download teaser or contact poster, please sign in.
i.e. 2.5% closing fee, 5% management fee, and 10-30% promote based on metrics being met.
Let's connect this week to discuss. We have deals in our pipeline, resources to conduct diligence, and elite operators to execute growth mandates post-close.